These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3504509)

  • 1. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology.
    Bodmeier R; McGinity JW
    J Microencapsul; 1987; 4(4):279-88. PubMed ID: 3504509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres.
    Bodmeier R; McGinity JW
    J Microencapsul; 1987; 4(4):289-97. PubMed ID: 3504510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies.
    Bodmeier R; McGinity JW
    J Microencapsul; 1988; 5(4):325-30. PubMed ID: 3236152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salt and cosolvent effects on ionic drug loading into microspheres using an O/W method.
    Al-Maaieh A; Flanagan DR
    J Control Release; 2001 Jan; 70(1-2):169-81. PubMed ID: 11166417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method.
    Bodmeier R; McGinity JW
    Pharm Res; 1987 Dec; 4(6):465-71. PubMed ID: 3508558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
    Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
    J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drug salt formation in biodegradable microspheres.
    Al-Maaieh A; Flanagan DR
    Int J Pharm; 2005 Oct; 303(1-2):153-9. PubMed ID: 16125886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method.
    Uchida T; Yoshida K; Goto S
    J Microencapsul; 1996; 13(2):219-28. PubMed ID: 8999126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheres.
    Lin SY; Chen KS; Teng HH
    J Microencapsul; 1998; 15(3):383-90. PubMed ID: 9608400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
    Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
    J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of neurotensin analogue-containing poly(dl-lactic acid) microspheres formed by oil-in-water solvent evaporation.
    Yamakawa I; Tsushima Y; Machida R; Watanabe S
    J Pharm Sci; 1992 Sep; 81(9):899-903. PubMed ID: 1432637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method.
    Yamakawa I; Tsushima Y; Machida R; Watanabe S
    J Pharm Sci; 1992 Aug; 81(8):808-11. PubMed ID: 1403728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
    Pavanetto F; Genta I; Giunchedi P; Conti B
    J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
    Parikh BV; Upadrashta SM; Neau SH; Nuessle NO
    J Microencapsul; 1993; 10(2):141-53. PubMed ID: 8331489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping neutral microclimate pH in PLGA microspheres.
    Li L; Schwendeman SP
    J Control Release; 2005 Jan; 101(1-3):163-73. PubMed ID: 15588902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of drug-loaded polylactic acid nanospheres and drug-releasing performance evaluation].
    Li L; Li GM; Huang WH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):352-4. PubMed ID: 15041563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of biodegradable or enteric-coated microspheres containing the protease inhibitor camostat.
    Uchida T; Yasuda N; Matsuyama K
    J Pharm Pharmacol; 2001 Feb; 53(2):255-61. PubMed ID: 11273024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.